Core Viewpoint - The State Council has approved the "Development Plan for Open Innovation of the Entire Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone," aiming to establish Jiangsu as a globally influential biopharmaceutical hub and enhance its international competitiveness in innovation [1][2]. Group 1: Key Tasks and Goals - The plan outlines 18 key tasks across 7 areas to enhance research and development capabilities, improve product approval services, build production and circulation systems, and strengthen support for essential resources [1]. - By 2030, the biopharmaceutical industry in the Jiangsu Free Trade Zone is expected to experience rapid growth, optimized innovation ecology, significant modernization of the industry chain, and improved levels of openness and security [1]. Group 2: Implementation and Collaboration - The Ministry of Commerce will collaborate with the Jiangsu provincial government and relevant departments to ensure the effective implementation of the plan's reform tasks and enhance regulatory cooperation [2]. - There is a focus on transforming pilot tasks into practical applications and converting innovative measures into tangible development outcomes to elevate the construction of the free trade zone [2].